Heterocyclylalkyl derivatives as novel inhibitors of histone...

Details Heterocyclylalkyl derivatives as novel inhibitors of histone... Heterocyclylalkyl derivatives as novel inhibitors of histone...

2007-01-16

2010-11-16

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S253130, C514S275000, C544S122000, C544S331000, C544S364000

Reexamination Certificate

active

07834011

ABSTRACT:
This invention comprises the novel compounds of formula (I)wherein R1, T, X, Y, A, n, m and p have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.

REFERENCES:
patent: 0827742 (1998-03-01), None
patent: 1472216 (2003-08-01), None
patent: 1485099 (2003-09-01), None
patent: 1485353 (2003-09-01), None
patent: 1495002 (2003-10-01), None
patent: 1501508 (2003-11-01), None
patent: 1525199 (2004-02-01), None
patent: 1572626 (2004-07-01), None
patent: 1585735 (2004-07-01), None
patent: 1590340 (2004-08-01), None
patent: 1592665 (2004-08-01), None
patent: 1592667 (2004-08-01), None
patent: 1608628 (2004-09-01), None
patent: 1613622 (2004-10-01), None
patent: 1485348 (2004-12-01), None
patent: 1485354 (2004-12-01), None
patent: 1485364 (2004-12-01), None
patent: 1485365 (2004-12-01), None
patent: 1485370 (2004-12-01), None
patent: 1485378 (2004-12-01), None
patent: 1492534 (2005-01-01), None
patent: 1581484 (2005-10-01), None
patent: 1611088 (2006-01-01), None
patent: WO-03/076422 (2003-09-01), None
patent: WO-03/076438 (2003-09-01), None
patent: WO 03/092686 (2003-11-01), None
patent: WO-2004/009536 (2004-01-01), None
patent: WO-2004/072047 (2004-08-01), None
patent: WO-2005/028447 (2005-03-01), None
patent: WO-2005/030704 (2005-04-01), None
patent: WO-2005/030705 (2005-04-01), None
patent: WO-2005/040101 (2005-05-01), None
patent: WO-2005/040161 (2005-05-01), None
patent: WO-2005/075469 (2005-08-01), None
patent: WO-2005/086898 (2005-09-01), None
patent: WO-2005/092899 (2005-10-01), None
Takai et al., PubMed Abstract (Cancer 101(12):2760-70), Dec. 2004.
Glaser, HDAC inhibitors: Clinical update and mechanism-based potential, Biochemical Pharmacology, 74, pp. 659-671, 2007.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1004-1010, 1996.
In the U.S. Patent and Trademark Office, Non-Final Office Action in re: U.S. Appl. No. 12/160,133 dated Sep. 29, 2009, 12 pages.
In the U.S. Patent and Trademark Office, Final Office Action in re: U.S. Appl. No. 12/090,771 dated Aug. 24, 2009, 6 pages.
In the U.S. Patent and Trademark Office, Non-Final Office Action in re: U.S. Appl. No. 12/090,771 dated Dec. 23, 2008, 11 pages.
In the U.S. Patent and Trademark Office, Non-Final Office Action in re: U.S. Appl. No. 11/626,215 dated Jul. 9, 2008, 14 pages.
Finnin et al., Structures of a Histone Deacetylase Homolgue Bound to the TSA and SAHA Inhibitors, Letters to Nature, 401: 188-193, 1999.
Mai et al., Histone Deacetylation in Epigenetics: An Attractive Target for Anticancer Therapy, Medicinal Research Reviews, 25 (3): 261-309, 2005.
T. Mosmann, Rapid Colorimetric Assay for Cellualar Growth and Survival: Application to Proliferation and Cytotoxicity Assays, Journal of Immunological Methods, 65: 55-63, 1983.
International Search Report for PCT/EP2007/050370 dated Mar. 14, 2007.

Affiliated with

Also associated with

Rating

Heterocyclylalkyl derivatives as novel inhibitors of histone... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclylalkyl derivatives as novel inhibitors of histone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclylalkyl derivatives as novel inhibitors of histone... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4177193